Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities.
Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand.
You can read more about our editorial policy here.
HanAll Biopharma and Harbour BioMed will develop two new medicines for the treatment of IgG-mediated autoimmune diseases, including myasthenia gravis (MG)…